Exabis Library
Welcome to the e-CCO Library!
P470: DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P470: Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P470: Evolution of asymptomatic unresected lesions in patients operated for multifocal Crohn's disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P470: Improving IBD-related pregnancy knowledge with a specialised preconception and pregnancy in IBD clinic
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P470: Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P470: Ustekinumab Trough Levels are not Associated with Clinical Response in Inflammatory Bowel Disease Patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P471 What is the appropriate cut-off value of CRP to predict endoscopic remission in ulcerative colitis patients with clinical remission?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P471: A Transcriptome-dependent Prognostic Model of Response in Patients with Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P471: Association of vedolizumab levels with clinical and biochemical markers of inflammation during maintenance therapy in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P471: Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real-world specialised hospital
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P471: Efficacy and safety of switching from reference infliximab to biosimilar infliximab in patients with inflammatory bowel disease: first French experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P471: Predictors of bowel damage in long term progression of Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P471: Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naïve and biologic exposed patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P471: Safety analysis of multimatrix mesalazine amongst patients with ulcerative colitis or recurrent diverticulitis ≥ 55 years of age
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P472 Optimising the development of apps for the management of inflammatory bowel disease and participation in clinical trials
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P472: Changes in colectomy for Ulcerative Colitis during the last two decades: an in-depth retrospective analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P472: Cyclosporine versus infliximab in patients with Acute Severe Ulcerative Colitis: A single-centre retrospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P472: Efficacy of intravenous ustekinumab re-induction in patients with Crohn’s disease with a loss of response
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P472: Faecal calprotectin as a biomarker of early mucosal healing in patients with ulcerative colitis naïve to adalimumab treatment
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P472: Impact of anti-TNF-alfa therapy on colectomy rates and indications for surgery in Ulcerative Colitis: Comparison of two patient cohorts from 2005 to 2007 and 2014 to 2016
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM